Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res Bull ; 57(5): 647-9, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11927368

ABSTRACT

The present study utilized the administration of the mitochondrial toxin, 3-nitropropionic acid (3-NP), to mimic the pathology associated with Huntington's disease (HD). 3-NP causes striatal cell degeneration via the inhibition of succinate dehydrogenase. There is growing evidence suggesting the role of apoptosis in 3-NP cell death. TUNEL staining, DNA fragmentation, and changes in bcl-2 mRNA levels have been associated with this metabolic impairment. We wish to further elucidate the apoptotic cascade in this model of HD pathogenesis. 3-NP was administered to rats intraperitoneally at 20mg/kg/day for up to 3 days. At 3 days, characteristic behavioral and morphological effects became evident. While cell death did not become apparent within the first 3 days, there were changes in the levels of apoptotic regulatory proteins and translocation of cytochrome c. Within 24 h after 3-NP administration there were elevations in both bcl-xl and bax. However, bcl-xl protein levels quickly returned to control levels while bax levels continued to increase, resulting in a detrimental bax/bcl-xl ratio. Bax has been demonstrated to facilitate cytochrome c release by forming mitochondrial pores. We saw cytochrome c translocate from the mitochondria to the cytosol approximately 24 h after initial 3-NP administration when compared to saline-injected controls. This evidence generated using the 3-NP degeneration model may help elucidate the apoptotic cascade associated with HD neurodegeneration.


Subject(s)
Apoptosis/physiology , Cytochrome c Group/metabolism , Huntington Disease/metabolism , Neostriatum/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins/metabolism , Up-Regulation/physiology , Animals , Apoptosis/drug effects , Behavior, Animal/drug effects , Behavior, Animal/physiology , Convulsants/pharmacology , Huntington Disease/chemically induced , Huntington Disease/physiopathology , Motor Activity/drug effects , Motor Activity/physiology , Neostriatum/drug effects , Neostriatum/physiopathology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Nitro Compounds , Propionates/pharmacology , Protein Transport/drug effects , Protein Transport/physiology , Proto-Oncogene Proteins/drug effects , Proto-Oncogene Proteins c-bcl-2/drug effects , Rats , Rats, Sprague-Dawley , Up-Regulation/drug effects , bcl-2-Associated X Protein , bcl-X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...